Supply Chain Research

There has been a surge in interest from global pharmaceutical companies in China’s single buyer program. The program, which sources generic drugs, has seen a 53% year over year drop in offered prices. It may provide a vehicle for China to meet part of its purchasing commitments made to the U.S. under the phase 1 trade deal. U.S. pharma exports to China reached $4.1 billion in the 12 months to Nov. 30 after rising 49.2% year over year. That growth would need to accelerate to 63.2% for each of 2020 and 2021 for pharma to contribute its proportionate share of China’s commitment to raise its...